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Abstract
Background: Physical activity decreases risk of colon polyps and colon cancer and might reduce risk of colon cancer
recurrence. Focusing on recent calls for translation of epidemiologic evidence into clinical care, our pilot study delivered an
evidence-based physical activity intervention in adults with polyps, who are thus at elevated risk of developing colon
cancer. The objective was to evaluate change in physical activity, measured by steps per day and minutes of moderate/
vigorous physical activity.
Methods: Sixteen adults with adenomas detected and removed at screening colonoscopy were recruited to a 12-week
physical activity intervention. Participants were randomized to receive a standard (30 minutes/day) or high (60 minutes/day)
walking program. Physical activity was measured via blinded pedometer and accelerometer at baseline and follow-up.
Intervention messages focused on self-monitoring using pedometers and overcoming barriers to engaging in physical
activity.
Results: Participants in both arms significantly increased objectively measured minutes of moderate/vigorous physical
activity over the course of the intervention. Both arms exceeded the intervention goal, but there was not a significant
difference between arms at follow-up. Results were similar for pedometer measured physical activity, with a significant
overall increase in steps/day from baseline to follow-up, but no between arm difference in change.
Conclusion: Simple interventions of minimal contact time focusing on walking can significantly increase physical activity in
individuals at increased risk of developing colon cancer.
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Introduction
Evidence linking regular physical activity with a reduced risk of
colon cancer is consistent and convincing [1–3]. A recent meta-
analysis of observational data found physical activity decreased risk
of adenomatous polyps which are precursors to colon cancer [4].
There is no evidence of an association for physical activity with
rectal cancer [2,5]. Despite the benefits of physical activity, nearly
75% of the population fails to meet recommended physical activity
levels [6–8].
Previous studies have reported a reduced risk of colon cancer
with engagement in moderate intensity activity [9,10]. Recent
analyses in the Nurses’ Health Study, the largest prospective study
to examine this association, found a significant risk reduction in
colon cancer incidence among women walking at least two hours
per week [11]. Observational data in colon cancer survivors shows
a disease-free survival benefit for physical activity, but suggests that
higher amounts of physical activity may be necessary to reduce risk
of recurrence [12,13]. Together, these data suggest there is a
favorable role for physical activity in terms of risk reduction, at
multiple stages in colon cancer carcinogenesis. However, there is
little data on the role of physical activity in individuals at elevated
risk of colon cancer, particularly those who have previously had
colon adenomatous polyps. We therefore interpreted a need for
data on whether a physical activity intervention could be
successfully implemented after removal of adenomatous polyps
during screening colonoscopy.
Designing such an intervention is challenging; the dose physical
activity necessary to reduce risk of recurrent colon adenomas is
unknown, as is whether increasing doses of physical activity would
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further modify the risk of adenoma recurrence. Data suggest that
physical activity equivalent to 30 minutes of walking/day is
adequate to reduce risk of developing colon cancer, while a higher
exercise dose (60 min/day) may be necessary to reduce colon
cancer recurrence and mortality. As physical activity interventions
often struggle to achieve the intervention target dose, determining
whether a higher dose is feasible is an important first step before
broader dissemination or implementation of physical activity
programs to prevent colon adenomas and cancer.
The overall objective of this study was to evaluate the feasibility
of a pilot intervention to deliver two doses of physical activity
delivered through an existing evidence-based walking intervention
paradigm to individuals who have had colon polyps and are thus
at increased risk for colon cancer. The First Step Program (FSP,
also published as Manpo-Kei) is an evidence and theoretically-
based two phase intervention that aims to promote uptake of and
adherence to physical activity, specifically walking, using pedom-
eters [14–22]. FSP addresses self-efficacy, outcome expectations
and social support in line with social cognitive theory and moves
participants through the phases of the Transtheoretical Model
[23]. The intervention focuses on home-based moderate intensity
walking with regular contact with study staff. FSP has repeatedly
been shown to successfully increase physical activity in patient
populations [16,24], and in community settings [15,22] Further-
more, the intervention successfully promoted a sustained increase
in steps/day when implemented in ‘‘real world’’ settings, using
existing diabetes educators and peer leaders [14] and in a
community setting [21], indicating the intervention is effective and
efficacious.
Pedometers are easy to use, relatively low cost, reliable and
accurate [25]. The combination of the high frequency of walking
as a physical activity and the comparatively low cost of pedometers
has made them a popular tool for population-based research, both
as a motivational and measurement device. Pedometer-based
interventions typically focus on a 10,000 steps per day goal, which
has support in clinical and monitored populations, [1,2,3] A
review of 32 observational and intervention studies suggests that
typical daily step counts range from: (1) 7–13,000 steps per day for
healthy younger adults; (2) 6–8,500 steps per day for healthy older
adults; and (3) 3,500–5,000 steps per day for sedentary individuals
and those with disabilities of chronic illness [26]. These findings
were corroborated in a study of urban African American adults
[27], but data on other racial/ethnic groups has not yet been
reported. Current research suggests step counts in the range of
3000–4000 steps are accumulated during 30-minutes of walking.
[4,5] Thus, for a healthy older adult, 10,000 steps would be
accumulated through usual daily activities plus a 30-minute walk,
making the 10,000 steps/day recommendation parallel to the
physical activity guidelines [6] Reviews of walking interventions
conclude that the use of pedometers [28] and telephone prompts
[29], as is done in the second phase of FSP, successfully increase
walking [30].
This study tested the feasibility of a pilot physical activity
intervention designed for individuals with a recently resected colon
adenoma. The focus of the study was on the development of an
intervention that would require minimal face-to-face contact time
to potentially improve future sustainability in clinical practice yet
still initiate physical activity behavior change.
Methods
In this study, we refined and pilot tested an evidence-based
intervention to promote walking among individuals with a
previous colon adenoma.
The Step Down Colon Cancer (SDCC) pilot tested an evidence-
based intervention to promote walking, using pedometers, among
individuals with a previous colon polyp (Protocol S1, Checklist S1).
SDCC is a 12-week two-arm randomized controlled trial program
prescribing two different doses (30 minutes vs 60 minutes) of
walking-based physical activity [17,31]. This study builds on
previous physical activity interventions with cancer outcomes
where 12 week interventions are common [32–36].
Recruitment
To identify eligible patients, staff in the hospital-based
gastroenterology practice reviewed practice records to identify
individuals potentially meeting preliminary eligibility criteria.
Study information was mailed to 399 men and women who
underwent resection of a colon adenoma during a routine
screening colonoscopy at Siteman Cancer Center. These individ-
uals received a letter from their gastroenterologist inviting them to
participate in the study. Individuals were then contacted by phone
to confirm eligibility if interested. Eligibility criteria included
individuals between the ages of 50 and 80 with no personal cancer
history who were diagnosed with adenomatous polyp upon
screening colonoscopy in previous 6 months and had no
contraindications to beginning an exercise program, no previous
diagnosis of diabetes, familial polyposis syndromes, ulcerative
colitis or Crohn’s disease. Individuals were ineligible if they
reported 30 or more minutes of moderate intensity physical
activity 5 or more days per week or 20 or more minutes of
vigorous intensity physical activity 3 or more days per week using
the Behavioral Risk Factor Surveillance System physical activity
questionnaire. Participants who were regular NSAID users also
were excluded because the study included an exploratory aim
examining change in serum inflammatory markers. The Wash-
ington University Institutional Review Board approved the study
and written consent was obtained from all participants.
Randomization
The allocation sequence was determined by random.org prior
to participant enrollment. Sequentially numbered envelopes
concealed the randomization to either group. The randomization
was sealed in an envelope by a blinded staff member. The
intervention coach opened the envelope following baseline
assessment and informed participants. A blinded staff member
completed all follow up data collection.
Intervention
The SDCC Pilot was a group-based intervention weekly for four
weeks followed by eight weeks of once-weekly phone-based follow-
up. Outside of group meeting times, which included a group walk,
participants were expected to walk on their own, progressing over
time to reach their respective study arm goal. In previous versions,
FSP has recommended a standard dose of 30 minutes of walking
and 10,000 steps per day. This is consistent with the current
federal physical activity guidelines for health [7]. Research in
colon cancer survivors suggests that 60 minutes of physical activity
is needed to prevent recurrence and improve survival [12,13] as
well as to manage weight [37], which is independently associated
with colon cancer risk [38]. Thus, we added a study arm that
delivered a higher dose of physical activity (60 minutes of walking,
13,000 steps per day).
The group sessions lasted four weeks and were led by
intervention coach. The sessions consisted of individual progress
reports, a brief walk of increasing duration, strategy discussion,
and individual goal setting for the following week. Between
sessions, participants walked on their own, wearing pedometers to
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self-monitor their daily steps. Participants logged their goals and
daily step counts to monitor their progress. Coaching sessions were
dedicated to different behavioral strategies each week. In week 1,
participants learned about step counting basics and goal setting
using the SMART (specific, measureable, attainable, realistic,
time-limited) system. In week 2, participants discuss barriers to
activity and the challenges of making trade-offs focusing on the
benefits of physical activity and the sacrifices that may come with
achieving their goal. During week 3, participants set new goals and
work to brainstorm strategies that can help them achieve their step
goal. In week 4, participants refine their goals and talk about
relapse prevention. The intervention was targeted to the partic-
ipant population by including discussion of the role of physical
activity in colon cancer etiology.
The SDCC 10,000 step goal is readily achievable for individuals
who are attaining already 6–8,000 steps/day in their usual daily
activity and are adding 30 (2–3,000 steps) minutes of additional
purposeful walking. However, data in chronically diseased and
sedentary populations indicates daily step counts are likely to be
much lower (3–5,000 steps/day) [26]. For those individuals whose
baseline step count is lower and in the higher dose arm, the coach
worked to progress them to a safe and reasonable goal driven by
the time goal (30 vs 60 minutes/da of walking) and using their
pedometer recorded step counts as a motivational and self-
monitoring tool. To maintain attendance rates, participants who
missed a session received follow-up calls and reminders for future
sessions. In phase two, participants received eight weeks of brief
phone support. Participants walked on their own, monitoring
progress using pedometers. Participants were contacted by phone
and asked to report their pedometer wear time, last daily step
count and were given the opportunity to ask questions or get
additional feedback as needed from the coordinator.
Measures
Data collection was completed at Washington University School
of Medicine. Baseline measures were taken prior to the initiation
of the intervention and follow-up measures following the last week
of intervention. To measure the outcome of step count change,
independent of self-monitoring, participants wore a sealed blinded
pedometer for one week at baseline and at follow-up and logged
their wear time. Participants had to report wearing the pedometer
for at least eight hours/day to be considered a valid day of wear.
Only valid wear days were included and the average steps/day
during the week was based only on days worn. We used the
Omron HJ 720 IT pedometer (Omron HealthCare, IL), which has
been shown to have higher validity in overweight and obese
individuals. Wear time was estimated based on the hourly counts
provided by the device output, which records counts per hour.
Participants also wore an Actigraph GT1M (Actigraph,
Pensacola, FL) accelerometer for one week at baseline and at
follow up to measure moderate/vigorous physical activity as an
additional outcome. The accelerometer had to be worn a
minimum of 10 hours to be considered a valid day. Data was
collected in 60 second epochs. Data was processed using the
ActiLife software (Actigraph, Pensacola, FL) and the Freedson
equation was used to define activity intensity cutpoints and time in
moderate/vigorous physical activity.
All study participants received $50 each for completing the
baseline and follow-up assessments. Participants were also given an
unblinded pedometer at the study conclusion.
Analysis
To be conservative in estimating the intervention effect, in all
analyses, participants who recorded baseline data, but did not
record follow-up data were included in the analyses; with the
baseline value carried forward as no change. Fisher’s exact tests
were used to compare demographics between the two study arms
because of small numbers in some cells. Paired t-tests were used to
examine change from baseline to follow-up. T-tests were used to
compare the intervention arms using an intent-to-treat analysis.
Results
Recruitment began in June 2009 and enrollment was completed
in December 2009. 265 of the 399 (66%) individuals sent an
invitation letter were reached and screened via telephone. 101 did
not meet inclusion criteria (38%) and 136 declined participation
(51%). 28 qualified for the intervention, and 17 consented and
enrolled. 16 were randomly assigned to one of two arms. One
participant was unable to commit to study requirements after
completing consent and baseline measures and was not random-
ized. 13 of the 16 enrolled (81%) completed the intervention (five
in the standard dose arm and eight in the high dose arm) and12
(75%) completed the accelerometer protocol (Consort Diagram
S1). The most common reasons for not qualifying were age,
disabled/unable to walk, and already exercising regularly. Of the 3
who did not complete the intervention, 1 was unable to commit to
the study requirements and 2 were lost to follow up. Of the 16
participants, 12 recorded 5 or more days of valid accelerometer
wear time, and 4 failed to meet the accelerometer wear time
requirements at baseline. Of the 13 participants who completed
the intervention, 12 recorded 5 or more days of valid accelerom-
eter wear time one recorded 4 days. Pedometer wear time was
similar, with 11 participants recording at least 5 days of valid wear
time, 2 participants recording 4 days, 2 participants had 3 days
and 1 had 2 days of valid wear time. At follow-up, 11 of the 13
participants recorded 5 or more valid days of pedometer wear
time, with the remaining 2 recording 1 day and 3 days,
respectively.
The population ranged in age from 45–66. 63% (n= 10) of the
participants were African American (Table S1) and most (81%)
were female. The participants were largely employed (63%) and
most had some post-high school education. There were no
significant differences between the two intervention arms on any
sociodemographic factors.
Participants recorded steps typical of chronically diseased
adults, with a mean of 4549 (standard deviation(sd) 2720) steps/
day at baseline (Table S2). Participants were also insufficiently
physically active as measured by accelerometer, recording 96 (sd
106) minutes/week of moderate/vigorous intensity physical
activity. The intervention significantly increased mean physical
activity levels, measured by blinded pedometer (1791 (sd 2065)
steps/day) and accelerometer (105 (sd117) minutes moderate/
vigorous intensity physical activity/week). Participants in the
standard dose arm increased moderate/vigorous activity by 65
(sd130) minutes/week and increased steps by 836 (sd 1284) per
day. In the high dose arm, participants increased steps by 2746 (sd
2325) per day and moderate/vigorous physical activity by 133
(sd107) minutes/week. Both arms failed to reach the intervention
daily step target, recording an average of 6340 (sd 3363) steps/day
at follow-up. However, this was a significant change from baseline
(p = 0.003). Despite not meeting the step count target at follow-up,
participants in both arms met the time-based exercise prescription,
recording a mean of over 200 minutes/week of moderate/
vigorous physical activity and qualifying them as meeting the US
Physical Activity Guidelines. This was also a significant increase
over baseline (p = 0.01).
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There was no significant difference between the arms in steps
per day or minutes of moderate/vigorous physical activity per
week at baseline. We found an increase in physical activity in both
arms as measured by accelerometer and blinded pedometer. The
difference between arms was not significant for accelerometer
measured physical activity (p = 0.34) and was marginally not
significant for steps (p = 0.07).
Discussion
Our pilot intervention yielded a significant increase in physical
activity as measured by two different objective measures-
accelerometer and blinded pedometer. Despite participants failing
to achieve the stated step count intervention target at follow-up for
either dose arm, participants did meet the intervention time-based
target dose in both arms. While the high (60 min/day) dose arm
had a target daily physical activity level that was twice current
physical activity recommendation, the higher dose arm did not
achieve a significantly higher level of physical activity than the
standard (30 min/day) dose arm.
Despite walking being the most commonly reported physical
activity [39,40], measuring walking presents numerous challenges,
including biased recall of occurrences, speed, and/or intensity
[41–43]. Thus, objective measurement tools that can detect
gradations in walking behavior are useful physical activity
measures. The step counts recorded by our population (mean
4549/day at baseline) were comparable to previous reports of
sedentary populations [26,27].
Pedometers are effective physical activity promotion tools as
they can provide immediate feedback in the form of step counts,
thereby facilitating individual-level behavior modification [44–47].
For example, a study by Croteau found that a minimal contact,
self-managed, pedometer-based intervention resulted in a signif-
icant increase in the average daily steps of participants from 8565
(+/23121) to 10538 (+/23681) at follow-up in 37 men and
women, a change of 1973 steps [45]. The impact of our
intervention was similar, though we noted that the change was
larger among those given a larger intervention target dose.
Despite not achieving the intervention step count target, both
arms recorded more than 150 minutes of moderate/vigorous
physical activity per week on the accelerometer at follow-up and
exceeded the intervention target dose for duration. This may
suggest that pedometer wear time was not complete during the
assessment periods, as the accelerometer physical activity estimates
employ an algorithm that accounts for daily wear time, or that the
pedometers underestimated the step count [48]. Our study was
also subject to other limitations, including our small sample size.
While the small sample size was part of the pilot study process, it
may have reduced our ability to detect differences in the
intervention arms.
Our response rate provides useful information for planning
recruitment to physical activity promotion programs in popula-
tions at increased risk for colon cancer. The response rate was
similar to other ‘‘cold contact’’ approaches to health behavior
research [49]. The study also has several strengths including our
reliance on an evidence-based intervention and objective assess-
ment of physical activity change.
This pilot intervention provided important information that can
be used in larger trials. This 12 week physical activity intervention
of minimal supervision can result in significant increases in
physical activity, sufficient to meet the US Physical Activity
Guidelines [7]. While pedometers are useful tools for self-
monitoring and physical activity promotion, their display interface
may induce reactivity such that they may not accurately reflect
changes in behavior during an intervention. We attempted to
minimize this by blinding the pedometer used for assessment
purposes, but participants also wore their intervention pedometer
at follow-up. Importantly, despite initial concerns that a target of
60 minutes/day would be too aggressive or difficult for this largely
sedentary population to achieve, both study arms increased
physical activity by more than twice the intervention recommen-
dation at follow-up. Some of this time likely reflects usual daily
activity, given the physical activity level recorded at baseline, but
the increase from baseline to follow-up was significant.
Our pilot study indicates that a minimal contact intervention
can generate significant changes in physical activity among
individuals at elevated risk for colon cancer. However, a more
contact-intensive intervention may be necessary to achieve the
target intervention dose and this should be evaluated in future
studies. Furthermore, because the study did not achieve the target
dose, the potential impact of the intervention on colon cancer risk
is not clear. Future studies should also evaluate whether this
minimal contact intervention results in changes in endpoints more
closely tied to colon cancer risk.
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